ondansetron has been researched along with Brain Injury, Chronic in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Brain Injury, Chronic: Conditions characterized by persistent brain damage or dysfunction as sequelae of cranial trauma. This disorder may result from DIFFUSE AXONAL INJURY; INTRACRANIAL HEMORRHAGES; BRAIN EDEMA; and other conditions. Clinical features may include DEMENTIA; focal neurologic deficits; PERSISTENT VEGETATIVE STATE; AKINETIC MUTISM; or COMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mandelcorn, J | 1 |
| Cullen, NK | 1 |
| Bayley, MT | 1 |
1 trial available for ondansetron and Brain Injury, Chronic
| Article | Year |
|---|---|
A preliminary study of the efficacy of ondansetron in the treatment of ataxia, poor balance and incoordination from brain injury.
Topics: Adult; Brain Injury, Chronic; Cerebellar Ataxia; Female; Humans; Male; Middle Aged; Neuropsychologic | 2004 |